Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Ready To Merge 500 Products Into Function-Based Payment System

This article was originally published in The Gray Sheet

Executive Summary

The Japanese Ministry of Health and Welfare is planning to complete the transfer of 55 categories of devices with incremental improvements - C-1 products - into the country's revamped "by-function" reimbursement system as early as this summer.

You may also be interested in...



QSRs Proposed As Alternatives To "Type Testing" In China and Korea

Chinese officials responsible for medical device regulation in China's State Drug Administration might participate in a proposed quality system regulation training program tentatively slated for late summer.

QSRs Proposed As Alternatives To "Type Testing" In China and Korea

Chinese officials responsible for medical device regulation in China's State Drug Administration might participate in a proposed quality system regulation training program tentatively slated for late summer.

Japan MHW To Set Payment Scheme, Reimbursement Levels By September

Japan's Ministry of Health and Welfare is expected to notify U.S. manufacturers the first week of September of the amount by which their devices will be reimbursed under the country's reorganized payment scheme, which is set to take effect on Oct. 1.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel